Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients

NCT06663358 is registered in ClinicalTrials.gov with Chiesi Farmaceutici S.p.A. as lead sponsor.

NCT NCT06663358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06663358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients
Lead sponsor
Chiesi Farmaceutici S.p.A.
Phase
Observational
Overall status
Recruiting
Start date
November 6, 2024
Completion date
November 30, 2029
Enrollment
100 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

fabry disease